Nursing Care Plan

Assessment (Subjective & Objective Data)

• Patient reports fever, body aches, headache, fatigue
• Reports cough, sore throat, and rhinorrhea consistent with influenza-like illness
• May report nausea, vomiting, or diarrhea

• Body temperature: 100.7°F (38.2°C)
• Confirmed or suspected H1N1 influenza A infection
• Tachycardia and tachypnea may be present secondary to elevated temperature
• Skin warm and flushed to touch
• Diaphoresis possible

Goal / Expected Outcomes

Nursing Interventions & Rationale

1. Temperature Monitoring

• Intervention: Monitor and document body temperature every 2-4 hours (or more frequently per facility protocol). Use a consistent, reliable method (oral, tympanic, or axillary).
• Rationale: Trending temperature patterns helps evaluate the effectiveness of antipyretic therapy and identifies progression or defervescence. Roberts and Hedges notes that oral temperature measurement requires attention to recent intake, as it can affect readings - Textbook of Family Medicine, 9e.

2. Antipyretic Administration

• Intervention: Administer acetaminophen (paracetamol) or ibuprofen as ordered per physician.
  • Acetaminophen: 325-650 mg orally every 4-6 hours (adult standard dose)
  • Ibuprofen: 400-600 mg orally every 6-8 hours (as an alternative or adjunct)
• Rationale: Both acetaminophen and ibuprofen are evidence-based antipyretics for fever management. Aspirin is avoided in viral illnesses due to risk of Reye syndrome. There is no need to cause patient discomfort with aggressive external cooling methods for fever control - Rosen's Emergency Medicine.

3. Antiviral Therapy Support

• Intervention: Administer oseltamivir (Tamiflu) as prescribed. Ensure it is started as early as possible - ideally within the first 48 hours of symptom onset. Monitor patient compliance and tolerance.
• Rationale: H1N1 influenza A is sensitive to neuraminidase inhibitors such as oseltamivir (Tamiflu) and zanamivir (Relenza). Antiviral treatment is most effective when started early after symptom onset. Treatment should not be delayed pending confirmatory test results - Textbook of Family Medicine, 9e.

4. Environmental Cooling Measures

• Intervention: Maintain a cool, well-ventilated room environment. Remove excess clothing or blankets. Apply a cool, damp cloth to the forehead, neck, or axillae if patient is comfortable with this.
• Rationale: Reducing external heat load supports the body's thermoregulation. Non-pharmacologic cooling methods are supportive but should not cause patient discomfort.

5. Fluid Replacement and Hydration

• Intervention: Encourage oral fluid intake of at least 2-3 liters per day (water, clear broths, electrolyte drinks) unless contraindicated. Monitor intake and output. Administer IV fluids if ordered or if the patient cannot tolerate oral intake.
• Rationale: Fever causes increased insensible fluid losses through diaphoresis and tachypnea, raising the risk of dehydration. Adequate hydration supports metabolic demands and helps maintain thermoregulation.

6. Respiratory Assessment and Precautions

• Intervention: Monitor respiratory rate, oxygen saturation (SpO2), and work of breathing every 4 hours. Apply droplet and contact precautions (surgical mask, gloves, gown). Isolate patient per institutional infection control protocols.
• Rationale: H1N1 influenza can progress rapidly to pneumonia and respiratory failure. Monitoring for pulmonary complications is essential. Influenza is transmitted via respiratory droplets; isolation prevents nosocomial spread - Textbook of Family Medicine, 9e.

7. Rest and Activity Management

• Intervention: Encourage bed rest during the febrile phase. Assist with activities of daily living. Cluster nursing care to minimize patient exertion.
• Rationale: Rest reduces metabolic demands and energy expenditure, supporting immune response and recovery. Exertion increases heat production, which can worsen hyperthermia.

8. Comfort Measures

• Intervention: Provide lightweight cotton clothing and breathable bed linens. Apply tepid sponge baths only if the patient is comfortable with the procedure. Offer cool oral fluids.
• Rationale: Comfort measures reduce the subjective distress of fever and promote patient cooperation with the care plan.

9. Neurological and Safety Monitoring

• Intervention: Monitor for signs of febrile seizure risk, confusion, or altered mental status. Ensure call bell is within reach and bed is in low position with side rails up.
• Rationale: High fevers, especially in vulnerable populations, can cause altered mentation. H1N1 has been associated with neurological complications in some patients.

10. Patient and Family Education

• Intervention: Educate patient and family on:
  • Importance of completing the full course of antiviral medication
  • Signs and symptoms of worsening - dyspnea, chest pain, persistent vomiting, confusion, cyanosis - which require immediate reporting
  • Hand hygiene and cough etiquette to prevent spread
  • Influenza vaccination for future prevention (H1N1 monovalent flu vaccine recommended)
• Rationale: Health education promotes adherence, early recognition of complications, and prevention of transmission. The Advisory Committee on Immunization Practices (ACIP) recommends H1N1 and seasonal flu vaccines - Textbook of Family Medicine, 9e.

Evaluation

Key Nursing Notes

• Aspirin is contraindicated in viral illness (including H1N1) due to risk of Reye syndrome.
• Antiviral therapy (oseltamivir) should be started within 48 hours of symptom onset for maximum benefit - Textbook of Family Medicine, 9e.
• Temperature of 100.7°F (38.2°C) represents true fever (not hyperthermia in the strict thermoregulatory sense); it is mediated by pyrogens and the hypothalamic set-point rise - pharmacologic antipyretics are appropriate first-line treatment.
• For temperatures >41°C (105.8°F), aggressive cooling measures (cooling blankets, ice packs) become a priority per Rosen's Emergency Medicine.
• Document all temperature readings, interventions, and patient response systematically.